Share This Page
Suppliers and packagers for timoptic
✉ Email this page to a colleague
timoptic
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | TIMOPTIC | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 018086 | NDA | Bausch & Lomb Incorporated | 24208-812-05 | 1 BOTTLE, DISPENSING in 1 CARTON (24208-812-05) / 5 mL in 1 BOTTLE, DISPENSING | 2016-12-30 |
| Bausch And Lomb Inc | TIMOPTIC | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 018086 | NDA | Bausch & Lomb Incorporated | 24208-813-05 | 1 BOTTLE, DISPENSING in 1 CARTON (24208-813-05) / 5 mL in 1 BOTTLE, DISPENSING | 2016-12-30 |
| Bausch And Lomb Inc | TIMOPTIC | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 018086 | NDA | Bausch & Lomb Incorporated | 24208-813-10 | 1 BOTTLE, DISPENSING in 1 CARTON (24208-813-10) / 10 mL in 1 BOTTLE, DISPENSING | 2016-12-30 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Timoptic
Introduction
Timoptic (generic name: timolol maleate) is a widely prescribed ophthalmic solution primarily used to treat open-angle glaucoma, ocular hypertension, and other conditions involving elevated intraocular pressure. As a β-blocker, Timoptic reduces aqueous humor production within the eye, effectively lowering intraocular pressure (IOP) and preventing optic nerve damage. The pharmaceutical landscape for Timoptic involves multiple manufacturers and suppliers, reflecting its longstanding clinical use and global demand.
This article provides a comprehensive overview of the primary suppliers for Timoptic, examining manufacturer profiles, supply chain dynamics, and key considerations for stakeholders. Identifying reliable suppliers is critical for healthcare providers, distributors, and pharmaceutical companies aiming to ensure consistent supply, regulatory compliance, and patient access.
Manufacturers of Timoptic
1. Novartis AG
History & Market Presence:
Novartis originally developed Timoptic in the 1970s. The drug became a leading ophthalmic therapy in the glaucoma treatment segment under the Novartis umbrella. Novartis's extensive global manufacturing network and rigorous quality standards make it a predominant supplier of Timoptic and its generics.
Manufacturing Facilities & Supply Capabilities:
Novartis operates manufacturing facilities in several countries, including Switzerland, the United States, and India, which enhance its capacity to meet international demand. Their facilities adhere to Good Manufacturing Practices (GMP) mandated by regulatory agencies like the FDA and EMA.
Product Variants & Formulations:
Apart from the iconic Timoptic formulation, Novartis offers various derivatives, including Timoptic-XE (gel-forming) and different concentrations, providing versatility across treatment protocols.
2. Sandoz (Novartis’s Generic Division)
Role & Significance:
Sandoz, a division of Novartis, specializes in producing high-quality generic ophthalmic formulations, including timolol maleate solutions. Given the patent expirations of Timoptic, Sandoz has become a key supplier of bioequivalent generics in multiple markets.
Manufacturing & Supply Chain:
Sandoz maintains GMP-compliant manufacturing sites globally, including in India, Europe, and North America, enabling competitive pricing and reliable supply for generic Timoptic.
3. Alcon (Novartis-Owned)
Historical Context:
Alcon, acquired by Novartis in 2010, is a major player in ophthalmic pharmaceutical manufacturing. Though Alcon now operates as an independent entity in some regions, it previously contributed to Timoptic’s production and continues to supply ophthalmic drugs globally.
Product Portfolio:
Alcon offers timolol-based products and other glaucoma therapies, often as part of combination therapies, expanding the supply scope of timolol formulations.
4. Lupin Limited
Market Role:
An Indian multinational, Lupin is one of the leading generic pharmaceutical producers globally. With a diversified product portfolio, Lupin manufactures timolol maleate ophthalmic solutions, serving markets in Asia, Africa, and Latin America.
Manufacturing & Quality:
Lupin’s manufacturing facilities in India and the U.S. follow stringent GMP standards, ensuring quality and regulatory compliance.
Regulatory Approvals:
Lupin’s Timoptic generics have gained approval from agencies such as the U.S. FDA and the Central Drugs Standard Control Organization (CDSCO) in India.
5. Aurobindo Pharma
Contribution to Timoptic Supply:
Aurobindo Pharma, another Indian-based manufacturer, produces timolol maleate ophthalmic solutions. Its focus on cost competitiveness and regulatory compliance maintains a steady supply stream for both domestic and international markets.
Supply Chain and Distribution Dynamics
Global Production & Regional Markets
The supply chain for Timoptic is characterized by regional manufacturing hubs—primarily in North America, Europe, and India—serving local demand and exporting to emerging markets. The globalized nature of pharmaceutical supply chains introduces risks such as regulatory delays, geopolitical disruptions, or raw material shortages.
Regulatory Compliance & Quality Assurance
Suppliers operate under strict oversight by agencies like the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and other national authorities. Manufacturers’ adherence to GMP standards guarantees product quality, safety, and efficacy, impacting supply stability.
Market Trends & Generic Competition
Patent expiry of the original Timoptic formulation catalyzed significant generic entry, lowering prices and expanding access. As generic manufacturers proliferate, the supply landscape becomes more competitive, ensuring availability but also requiring vigilance against counterfeit or substandard products.
Key Considerations for Stakeholders
- Quality & Regulatory Certification: Buyers should prioritize suppliers with robust GMP compliance and approved manufacturing facilities by relevant regulatory agencies.
- Supply Reliability: Engage with established manufacturers with proven track records for consistent supply to avoid shortages, especially in high-demand regions.
- Pricing & Cost Dynamics: Generics providers like Lupin and Aurobindo offer competitive pricing, crucial for cost-sensitive healthcare systems.
- Geographical Reach: For procurement, consider suppliers with extensive regional distribution networks to ensure timely delivery.
- Product Variants: Suppliers offering multiple formulations (e.g., gel-forming, combination therapy) provide flexibility to clinicians and pharmacies.
Future Outlook
The global demand for glaucoma treatments remains steady due to aging populations and increasing prevalence rates. The role of generics and biosimilars is set to grow, expanding the supplier base for timolol maleate ophthalmic solutions. Innovations such as sustained-release formulations and combination therapies may influence supply chain dynamics further. Manufacturers investing in scalable manufacturing capacity and regulatory market access will shape the future landscape for Timoptic suppliers.
Key Takeaways
- Major suppliers for Timoptic include Novartis (and its division Sandoz), Alcon, Lupin, and Aurobindo Pharma, among others.
- Manufacturers maintain compliance with GMP standards aligning with global regulatory agencies like the FDA and EMA.
- The global supply chain features regional manufacturing hubs, with Indian firms offering cost-effective options.
- Market competition from generics has improved supply availability and lowered prices but necessitates vigilance to quality.
- Future growth hinges on innovations in glaucoma therapy and continued manufacturing capacity expansion.
FAQs
Q1: Who are the leading manufacturers of Timoptic globally?
A1: The leading manufacturers include Novartis (its original formulation), Sandoz (generic division of Novartis), Lupin, and Aurobindo Pharma, with Alcon historically involved.
Q2: Are generic versions of Timoptic reliable?
A2: Yes, high-quality generics from approved manufacturers like Lupin and Aurobindo adhere to strict GMP standards, offering bioequivalent options at reduced costs.
Q3: What factors should healthcare providers consider when sourcing Timoptic?
A3: Providers should evaluate supplier regulatory approval, manufacturing quality, supply reliability, and formulation options.
Q4: How does patent expiry affect Timoptic supply?
A4: Patent expiration led to an influx of generic manufacturers, increasing supply options and reducing prices.
Q5: Are Asian manufacturers a significant part of Timoptic’s supply chain?
A5: Yes, Indian firms such as Lupin and Aurobindo form a substantial segment of the generic supply chain, offering cost-effective options globally.
References
- Novartis AG. "Timoptic Product Information." [2022].
- U.S. Food and Drug Administration. "Drug Establishments Inspection Reports." [2023].
- Lupin Limited. "Product Portfolio and Regulatory Approvals." [2023].
- Aurobindo Pharma. "Quality and Compliance Certifications." [2023].
- MarketWatch. "Global Ophthalmic Drugs Market Outlook." [2022].
This detailed analysis aims to assist stakeholders in making informed procurement and strategic decisions relating to Timoptic supply chain management.
More… ↓
